Motif Bio plc Warrants to Purchase ADRs
MTFBW
MTFBW was delisted on the 16th of December, 2019.
0 hedge funds and large institutions have $0 invested in Motif Bio plc Warrants to Purchase ADRs in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.
100% less funds holding
Funds holding: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $14K → $0 (-$14K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$12K |
| 2 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Invesco
Atlanta,
Georgia
| – | -$12K | -545,400 | Closed |
|
|
SGCM
2
Sand Grove Capital Management
London,
United Kingdom
| – | -$2K | -97,200 | Closed |
|
MTFBW Hedge Fund Activity: Q4 2019 in Review
0 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc Warrants to Purchase ADRs (MTFBW) for Q4 2019, worth a combined $0 — down 100% from $14K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of MTFBW and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Invesco, exiting entirely with an estimated $12K sold.
- 0 institutional investors held Motif Bio plc Warrants to Purchase ADRs (MTFBW) as of Q4 2019, down from 4 in Q3 2019.
- Funds reported $0 of Motif Bio plc Warrants to Purchase ADRs stock for Q4 2019, down 100% quarter-over-quarter.
- 0 funds opened new Motif Bio plc Warrants to Purchase ADRs positions in Q4 2019 and 4 closed out, a net change of -4 holders.
- The largest Motif Bio plc Warrants to Purchase ADRs seller in Q4 2019 was Invesco, an estimated $12K sold.
Based on aggregated 13F filings for Q4 2019.